Search research articles
Contact Us
Filters
Showing results (21-30 of 45) with videos related to
Page
of 5
Sort By:
Journal of Clinical Pharmacology
|
February 1, 1988
Pharmacokinetics of roxithromycin (RU 965)
H B Lassman, S K Puri, I Ho, et al.
Immunopharmacology
|
April 2, 1999
Effects of single intravenous doses of recombinant human interleukin-10 on subsets of circulating leukocytes in humans
R D Huhn, K Pennline, E Radwanski, et al.
Physical Review Letters
|
August 16, 2011
Characterizing neutral modes of fractional states in the second Landau level
M Dolev, Y Gross, R Sabo, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
December 24, 1997
Activity and tolerance of a continuous subcutaneous infusion of interferon-alpha2b in patients with chronic hepatitis C
S Schenker, D Cutler, J Finch, et al.
Hypertension (Dallas, Tex. : 1979)
|
August 12, 2022
Evolving Concepts in Uromodulin Biology, Physiology, and Its Role in Disease: a Tale of Two Forms
Kaice A LaFavers, Radmila Micanovic, Angela R Sabo, et al.
Clinical Pharmacology and Therapeutics
|
December 5, 2000
Pegylated interferon-alpha2b: pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data. Hepatitis C Intervention Therapy Group
P Glue, J W Fang, R Rouzier-Panis, et al.
Hepatology (Baltimore, Md.)
|
August 29, 2000
A dose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C. The Hepatitis C Intervention Therapy Group
P Glue, R Rouzier-Panis, C Raffanel, et al.
Clinical Pharmacology and Therapeutics
|
August 1, 1997
Pharmacodynamics of subcutaneous recombinant human interleukin-10 in healthy volunteers
R D Huhn, E Radwanski, J Gallo, et al.
Toxicology and Industrial Health
|
December 25, 2008
Induction of micronuclei in rat bone marrow after chronic exposure to lead acetate trihydrate
M A Alghazal, I Sutiaková, N Kovalkovicová, et al.
Biorxiv : the Preprint Server for Biology
|
May 13, 2026
Uromodulin promotes immune zonation and inhibits alternative inflammasome-mediated activation of immune-to-collecting duct inflammatory signaling in early acute kidney injury
Angela R Sabo, Azuma Nanamatsu, Dillen Wischmeier, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 45) with videos related to
Sort By:
Page
of 5
Journal of Clinical Pharmacology
|
February 1, 1988
Pharmacokinetics of roxithromycin (RU 965)
H B Lassman, S K Puri, I Ho, et al.
Immunopharmacology
|
April 2, 1999
Effects of single intravenous doses of recombinant human interleukin-10 on subsets of circulating leukocytes in humans
R D Huhn, K Pennline, E Radwanski, et al.
Physical Review Letters
|
August 16, 2011
Characterizing neutral modes of fractional states in the second Landau level
M Dolev, Y Gross, R Sabo, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
December 24, 1997
Activity and tolerance of a continuous subcutaneous infusion of interferon-alpha2b in patients with chronic hepatitis C
S Schenker, D Cutler, J Finch, et al.
Hypertension (Dallas, Tex. : 1979)
|
August 12, 2022
Evolving Concepts in Uromodulin Biology, Physiology, and Its Role in Disease: a Tale of Two Forms
Kaice A LaFavers, Radmila Micanovic, Angela R Sabo, et al.
Clinical Pharmacology and Therapeutics
|
December 5, 2000
Pegylated interferon-alpha2b: pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data. Hepatitis C Intervention Therapy Group
P Glue, J W Fang, R Rouzier-Panis, et al.
Hepatology (Baltimore, Md.)
|
August 29, 2000
A dose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C. The Hepatitis C Intervention Therapy Group
P Glue, R Rouzier-Panis, C Raffanel, et al.
Clinical Pharmacology and Therapeutics
|
August 1, 1997
Pharmacodynamics of subcutaneous recombinant human interleukin-10 in healthy volunteers
R D Huhn, E Radwanski, J Gallo, et al.
Toxicology and Industrial Health
|
December 25, 2008
Induction of micronuclei in rat bone marrow after chronic exposure to lead acetate trihydrate
M A Alghazal, I Sutiaková, N Kovalkovicová, et al.
Biorxiv : the Preprint Server for Biology
|
May 13, 2026
Uromodulin promotes immune zonation and inhibits alternative inflammasome-mediated activation of immune-to-collecting duct inflammatory signaling in early acute kidney injury
Angela R Sabo, Azuma Nanamatsu, Dillen Wischmeier, et al.
Page
of 5